Preventive Medication Adherence in African American and Caucasian Headache Patients
Identifieur interne : 001F16 ( Istex/Corpus ); précédent : 001F15; suivant : 001F17Preventive Medication Adherence in African American and Caucasian Headache Patients
Auteurs : Bernadette D. Heckman ; Gary EllisSource :
- Headache: The Journal of Head and Face Pain [ 0017-8748 ] ; 2011-04.
Abstract
(Headache 2011;51:520‐532) Study Objectives.— To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients. Methods.— Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month). Results.— The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy. Conclusions.— Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.
Url:
DOI: 10.1111/j.1526-4610.2011.01866.x
Links to Exploration step
ISTEX:8EF7539930E57B348997E197C425A36C95B1364BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preventive Medication Adherence in African American and Caucasian Headache Patients</title><author><name sortKey="Heckman, Bernadette D" sort="Heckman, Bernadette D" uniqKey="Heckman B" first="Bernadette D." last="Heckman">Bernadette D. Heckman</name><affiliation><mods:affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</mods:affiliation></affiliation></author><author><name sortKey="Ellis, Gary" sort="Ellis, Gary" uniqKey="Ellis G" first="Gary" last="Ellis">Gary Ellis</name><affiliation><mods:affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8EF7539930E57B348997E197C425A36C95B1364B</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1526-4610.2011.01866.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001F16</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Preventive Medication Adherence in African American and Caucasian Headache Patients</title><author><name sortKey="Heckman, Bernadette D" sort="Heckman, Bernadette D" uniqKey="Heckman B" first="Bernadette D." last="Heckman">Bernadette D. Heckman</name><affiliation><mods:affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</mods:affiliation></affiliation></author><author><name sortKey="Ellis, Gary" sort="Ellis, Gary" uniqKey="Ellis G" first="Gary" last="Ellis">Gary Ellis</name><affiliation><mods:affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Headache: The Journal of Head and Face Pain</title><title level="j" type="alt">HEADACHE JOURNAL HEAD FACE PAIN</title><idno type="ISSN">0017-8748</idno><idno type="eISSN">1526-4610</idno><imprint><biblScope unit="vol">51</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="520">520</biblScope><biblScope unit="page" to="532">532</biblScope><biblScope unit="page-count">13</biblScope><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-04">2011-04</date></imprint><idno type="ISSN">0017-8748</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0017-8748</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">(Headache 2011;51:520‐532) Study Objectives.— To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients. Methods.— Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month). Results.— The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy. Conclusions.— Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>african american</json:string><json:string>medication adherence</json:string><json:string>medication</json:string><json:string>caucasian</json:string><json:string>headache patient</json:string><json:string>pretreatment</json:string><json:string>adherence datum</json:string><json:string>headache</json:string><json:string>predictor</json:string><json:string>preventive headache agent</json:string><json:string>migraine</json:string><json:string>datum</json:string><json:string>hmse</json:string><json:string>depressive</json:string><json:string>headache disorder</json:string><json:string>african american patient</json:string><json:string>adherence</json:string><json:string>medication regimen</json:string><json:string>antiretroviral</json:string><json:string>caucasian patient</json:string><json:string>cephalalgia</json:string><json:string>adherence rate</json:string><json:string>african american headache patient</json:string><json:string>regimen</json:string><json:string>more likely</json:string><json:string>preventive medication agent</json:string><json:string>headache frequency</json:string><json:string>current study</json:string><json:string>past month</json:string><json:string>preventive therapy</json:string><json:string>preventive medication</json:string><json:string>study finding</json:string><json:string>health psychol</json:string><json:string>headache episode severity</json:string><json:string>heckman</json:string><json:string>pretreatment visit</json:string><json:string>social support</json:string><json:string>chronic health condition</json:string><json:string>poorer medication adherence</json:string><json:string>depressive symptom</json:string><json:string>major depressive disorder</json:string><json:string>less likely</json:string><json:string>daily diary</json:string><json:string>antiretroviral therapy</json:string><json:string>treatment initiation</json:string><json:string>mental disorder</json:string><json:string>treatment outcome</json:string><json:string>consistent adherence</json:string><json:string>headache diary</json:string><json:string>race headache frequency</json:string><json:string>race headache severity</json:string><json:string>regression analysis</json:string><json:string>preventive medication adherence</json:string><json:string>headache diagnosis</json:string><json:string>preventive agent</json:string><json:string>depressed headache patient</json:string><json:string>logistic regression analysis</json:string><json:string>caucasian headache patient</json:string><json:string>frequent headache</json:string><json:string>clinic</json:string><json:string>second visit</json:string><json:string>outcome expectation</json:string><json:string>patient complete</json:string><json:string>exploratory univariate logistic regression analysis</json:string><json:string>migraine patient</json:string><json:string>psychosocial headache measure</json:string><json:string>study enrollment</json:string><json:string>aid care</json:string><json:string>study physician</json:string><json:string>exploratory study</json:string><json:string>headache episode</json:string><json:string>less research</json:string><json:string>individual predictor</json:string><json:string>medication adherence more</json:string><json:string>poor adherence</json:string><json:string>headache medication</json:string><json:string>greater hmse</json:string><json:string>study hypothesis</json:string><json:string>annual income</json:string><json:string>ohio university</json:string><json:string>more severe</json:string><json:string>demographic variable</json:string><json:string>headache management</json:string><json:string>other chronic health condition</json:string><json:string>acute medication</json:string><json:string>headache severity</json:string><json:string>medication adherence group</json:string><json:string>primary care evaluation</json:string><json:string>preventive headache medication</json:string><json:string>lower level</json:string><json:string>racerelated difference</json:string><json:string>headache activity</json:string><json:string>treatment appointment nonattendance</json:string><json:string>factor such</json:string><json:string>racial difference</json:string><json:string>prescription refill</json:string><json:string>headache subspecialty clinic</json:string><json:string>race difference</json:string><json:string>heart failure</json:string><json:string>aid behav</json:string><json:string>chronic headache</json:string><json:string>glycemic control</json:string><json:string>headache medication regimen</json:string><json:string>logistic</json:string><json:string>disorder</json:string><json:string>poorer</json:string></teeft></keywords><author><json:item><name>Bernadette D. Heckman PhD</name><affiliations><json:string>From the Department of Psychology, Ohio University, Athens, OH, USA.</json:string></affiliations></json:item><json:item><name>Gary Ellis MS</name><affiliations><json:string>From the Department of Psychology, Ohio University, Athens, OH, USA.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>headache</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>medication adherence</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>race‐related health disparities</value></json:item></subject><articleId><json:string>HEAD1866</json:string></articleId><arkIstex>ark:/67375/WNG-2Q6Q0P7D-5</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>(Headache 2011;51:520‐532) Study Objectives.— To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients. Methods.— Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month). Results.— The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy. Conclusions.— Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.</abstract><qualityIndicators><score>9.34</score><pdfWordCount>6095</pdfWordCount><pdfCharCount>44297</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>13</pdfPageCount><pdfPageSize>594 x 783 pts</pdfPageSize><pdfWordsPerPage>469</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>195</abstractWordCount><abstractCharCount>1528</abstractCharCount><keywordCount>3</keywordCount></qualityIndicators><title>Preventive Medication Adherence in African American and Caucasian Headache Patients</title><pmid><json:string>21457237</json:string></pmid><genre><json:string>article</json:string></genre><host><title>Headache: The Journal of Head and Face Pain</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1526-4610</json:string></doi><issn><json:string>0017-8748</json:string></issn><eissn><json:string>1526-4610</json:string></eissn><publisherId><json:string>HEAD</json:string></publisherId><volume>51</volume><issue>4</issue><pages><first>520</first><last>532</last><total>13</total></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2011</json:string><json:string>Between July 2004 and June 2008</json:string></date><geogName></geogName><orgName><json:string>Headache Classification Subcommittee of the International Headache Society</json:string><json:string>Department of Psychology, Ohio University, Athens, OH</json:string><json:string>Being African American Headache</json:string><json:string>National Institute of Neurological Disorders and Stroke</json:string><json:string>INSIGHT Research Team</json:string><json:string>African American and Caucasian Headache Patients</json:string><json:string>African American and Caucasian</json:string><json:string>American Headache Society Research Submission Preventive Medication Adherence</json:string><json:string>Department of Psychology, Ohio University, Athens, OH, USA</json:string><json:string>African American Patients</json:string><json:string>for the US Headache Consortium</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Americans</json:string><json:string>B.D. Heckman</json:string><json:string>Predictor</json:string><json:string>Headache</json:string><json:string>Characteristic</json:string><json:string>Ken Holroyd</json:string><json:string>B. Heckman</json:string><json:string>Gary Ellis</json:string></persName><placeName><json:string>Columbus</json:string><json:string>American</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>April 2011</json:string><json:string>Mullerners et al</json:string><json:string>Packard et al</json:string><json:string>Steiner et al</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-2Q6Q0P7D-5</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - clinical neurology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - neurology & neurosurgery</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Clinical Neurology</json:string><json:string>1 - Life Sciences</json:string><json:string>2 - Neuroscience</json:string><json:string>3 - Neurology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1111/j.1526-4610.2011.01866.x</json:string></doi><id>8EF7539930E57B348997E197C425A36C95B1364B</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Preventive Medication Adherence in African American and Caucasian Headache Patients</title><title level="a" type="short">April 2011</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><availability><licence>© 2011 American Headache Society</licence></availability><date type="published" when="2011-04"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Preventive Medication Adherence in African American and Caucasian Headache Patients</title><title level="a" type="short">April 2011</title><author xml:id="author-0000"><persName><forename type="first">Bernadette D.</forename><surname>Heckman</surname><roleName type="degree">PhD</roleName></persName><affiliation><orgName type="department">From the Department of Psychology</orgName><orgName type="institution">Ohio University</orgName><address><addrLine>Athens</addrLine><addrLine>OH, USA.</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Gary</forename><surname>Ellis</surname><roleName type="degree">MS</roleName></persName><affiliation><orgName type="department">From the Department of Psychology</orgName><orgName type="institution">Ohio University</orgName><address><addrLine>Athens</addrLine><addrLine>OH, USA.</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><idno type="istex">8EF7539930E57B348997E197C425A36C95B1364B</idno><idno type="ark">ark:/67375/WNG-2Q6Q0P7D-5</idno><idno type="DOI">10.1111/j.1526-4610.2011.01866.x</idno><idno type="unit">HEAD1866</idno><idno type="toTypesetVersion">file:HEAD.HEAD1866.pdf</idno></analytic><monogr><title level="j" type="main">Headache: The Journal of Head and Face Pain</title><title level="j" type="alt">HEADACHE JOURNAL HEAD FACE PAIN</title><idno type="pISSN">0017-8748</idno><idno type="eISSN">1526-4610</idno><idno type="book-DOI">10.1111/(ISSN)1526-4610</idno><idno type="book-part-DOI">10.1111/hed.2011.51.issue-4</idno><idno type="product">HEAD</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">51</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="520">520</biblScope><biblScope unit="page" to="532">532</biblScope><biblScope unit="page-count">13</biblScope><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-04"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><p>(<hi rend="italic">Headache</hi> 2011;51:520‐532)</p><p><hi rend="bold">Study Objectives.—</hi> To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients.</p><p><hi rend="bold">Methods.—</hi> Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month).</p><p><hi rend="bold">Results.—</hi> The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy.</p><p><hi rend="bold">Conclusions.—</hi> Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="k1">headache</term><term xml:id="k2">medication adherence</term><term xml:id="k3">race‐related health disparities</term></keywords><keywords rend="tocHeading1"><term>Research Submissions</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Inc</publisherName><publisherLoc>Malden, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1526-4610</doi><issn type="print">0017-8748</issn><issn type="electronic">1526-4610</issn><idGroup><id type="product" value="HEAD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="HEADACHE JOURNAL HEAD FACE PAIN">Headache: The Journal of Head and Face Pain</title></titleGroup></publicationMeta><publicationMeta level="part" position="04104"><doi origin="wiley">10.1111/hed.2011.51.issue-4</doi><numberingGroup><numbering type="journalVolume" number="51">51</numbering><numbering type="journalIssue" number="4">4</numbering></numberingGroup><coverDate startDate="2011-04">April 2011</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="3" status="forIssue"><doi origin="wiley">10.1111/j.1526-4610.2011.01866.x</doi><idGroup><id type="unit" value="HEAD1866"></id></idGroup><countGroup><count type="pageTotal" number="13"></count></countGroup><titleGroup><title type="tocHeading1">Research Submissions</title></titleGroup><copyright>© 2011 American Headache Society</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.4.8 mode:FullText" date="2011-04-01"></event><event type="firstOnline" date="2011-04-01"></event><event type="publishedOnlineFinalForm" date="2011-04-01"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-26"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-23"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="520">520</numbering><numbering type="pageLast" number="532">532</numbering></numberingGroup><correspondenceTo>B.D. Heckman, Department of Psychology, Ohio University, Athens, OH 45701, USA.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:HEAD.HEAD1866.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted for publication January 23, 2011.</unparsedEditorialHistory><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="4"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="58"></count><count type="wordTotal" number="5095"></count><count type="linksPubMed" number="0"></count><count type="linksCrossRef" number="0"></count></countGroup><titleGroup><title type="main">Preventive Medication Adherence in African American and Caucasian Headache Patients</title><title type="shortAuthors">Headache</title><title type="short">April 2011</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#aff-1-1"><personName><givenNames>Bernadette D.</givenNames><familyName>Heckman</familyName><degrees>PhD</degrees></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#aff-1-1"><personName><givenNames>Gary</givenNames><familyName>Ellis</familyName><degrees>MS</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="aff-1-1" countryCode="US"><unparsedAffiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">headache</keyword><keyword xml:id="k2">medication adherence</keyword><keyword xml:id="k3">race‐related health disparities</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>(<i>Headache</i> 2011;51:520‐532)</p><p><b>Study Objectives.—</b> To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients.</p><p><b>Methods.—</b> Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month).</p><p><b>Results.—</b> The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy.</p><p><b>Conclusions.—</b> Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p><inlineGraphic alt="inline image" location="image_n/HEAD_1866_fu1.gif" href=""></inlineGraphic> To download a podcast featuring further discussion of this article, please visit <url href="http://www.headachejournal.org">http://www.headachejournal.org</url></p></note><note xml:id="fn2"><p><i>Conflict of Interest:</i> There are no conflicts of interests associated with this study.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Preventive Medication Adherence in African American and Caucasian Headache Patients</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>April 2011</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Preventive Medication Adherence in African American and Caucasian Headache Patients</title></titleInfo><name type="personal"><namePart type="given">Bernadette D.</namePart><namePart type="family">Heckman</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gary</namePart><namePart type="family">Ellis</namePart><namePart type="termsOfAddress">MS</namePart><affiliation>From the Department of Psychology, Ohio University, Athens, OH, USA.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Inc</publisher><place><placeTerm type="text">Malden, USA</placeTerm></place><dateIssued encoding="w3cdtf">2011-04</dateIssued><edition>Accepted for publication January 23, 2011.</edition><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">1</extent><extent unit="tables">4</extent><extent unit="formulas">0</extent><extent unit="references">58</extent><extent unit="linksCrossRef">0</extent><extent unit="words">5095</extent></physicalDescription><abstract lang="en">(Headache 2011;51:520‐532) Study Objectives.— To examine race‐related differences in adherence to preventive medication agents in headache patients and identify factors predictive of medication adherence in Caucasian and African American headache patients. Methods.— Using a longitudinal naturalistic study design, data from 77 Caucasian and 32 African American headache patients were collected through (1) 30‐day daily diaries that assessed medication adherence, headache frequency, and headache episode severity; (2) self‐administered surveys that assessed headache management self‐efficacy; and (3) telephone‐administered psychiatric interviews that yielded psychiatric diagnoses. Using daily diary adherence data, patients' adherence to preventive agents was dichotomized as “Inconsistent” (ie, adhered fewer than 80% of days) or “Consistent” (ie, adhered ≥80% of days during the past month). Results.— The proportion of adherent African American patients (69%) did not differ significantly from the proportion of adherent Caucasian patients (82%). Exploratory univariate logistic regression analyses found that preventive medication adherence levels of 80% or less were associated with being diagnosed with major depressive disorder and lower levels of headache management self‐efficacy. Conclusions.— Future research should test if interventions that reduce depressive symptoms and increase patients' levels of headache management self‐efficacy can produce concomitant increases in adherence to preventive headache agents.</abstract><subject lang="en"><genre>keywords</genre><topic>headache</topic><topic>medication adherence</topic><topic>race‐related health disparities</topic></subject><relatedItem type="host"><titleInfo><title>Headache: The Journal of Head and Face Pain</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0017-8748</identifier><identifier type="eISSN">1526-4610</identifier><identifier type="DOI">10.1111/(ISSN)1526-4610</identifier><identifier type="PublisherID">HEAD</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>51</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>520</start><end>532</end><total>13</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Variations in patients' adherence to medication recommendations: A quantitative review of 50 years of research</title></titleInfo><name type="personal"><namePart type="given">MR</namePart><namePart type="family">DiMatteo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">DiMatteo MR. Variations in patients' adherence to medication recommendations: A quantitative review of 50 years of research. Med Care. 2004;42:200‐209.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>200</start><end>209</end></extent></part><relatedItem type="host"><titleInfo><title>Med Care</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>200</start><end>209</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Adherence to medication</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Osterberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Blaschke</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487‐497.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>353</number></detail><extent unit="pages"><start>487</start><end>497</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>353</number></detail><extent unit="pages"><start>487</start><end>497</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>The DARTS/MEMO collaboration: Adherence to prescribed oral hypoglycemic medication in a population of patients with type two diabetes: A retrospective study</title></titleInfo><name type="personal"><namePart type="given">PT</namePart><namePart type="family">Donnan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TM</namePart><namePart type="family">MacDonald</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Morris</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Donnan PT, MacDonald TM, Morris AP. The DARTS/MEMO collaboration: Adherence to prescribed oral hypoglycemic medication in a population of patients with type two diabetes: A retrospective study. Diabetes Med. 2002;19:279‐284.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>279</start><end>284</end></extent></part><relatedItem type="host"><titleInfo><title>Diabetes Med</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>279</start><end>284</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Non‐adherence in hemodialysis: Association with mortality, hospitalization, and practice patterns in the DOPPS</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Saran</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Bragg‐Gresham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HC</namePart><namePart type="family">Rayner</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Saran R, Bragg‐Gresham JL, Rayner HC, et al. Non‐adherence in hemodialysis: Association with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254‐262.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>254</start><end>262</end></extent></part><relatedItem type="host"><titleInfo><title>Kidney Int</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><extent unit="pages"><start>254</start><end>262</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction</title></titleInfo><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Peterson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Wright</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ED</namePart><namePart type="family">Person</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Peterson LA, Wright SM, Person ED, et al. Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction. Med Care. 2002;40:186‐196.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>186</start><end>196</end></extent></part><relatedItem type="host"><titleInfo><title>Med Care</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>186</start><end>196</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia</title></titleInfo><name type="personal"><namePart type="given">PJ</namePart><namePart type="family">Weiden</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Kozma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Grogg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Locklear</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weiden PJ, Kozma C, Grogg A, Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiat Serv. 2004;55:886‐891.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>886</start><end>891</end></extent></part><relatedItem type="host"><titleInfo><title>Psychiat Serv</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>886</start><end>891</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>Precipitating factors leading to decompensated of heart failure: Traits among urban blacks</title></titleInfo><name type="personal"><namePart type="given">JK</namePart><namePart type="family">Ghali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kadakia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Ferlinez</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ghali JK, Kadakia S, Cooper R, Ferlinez J. Precipitating factors leading to decompensated of heart failure: Traits among urban blacks. Arch Intern Med. 1988;148:2013‐2016.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>148</number></detail><extent unit="pages"><start>2013</start><end>2016</end></extent></part><relatedItem type="host"><titleInfo><title>Arch Intern Med</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>148</number></detail><extent unit="pages"><start>2013</start><end>2016</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Treatment adherence in chronic disease</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dunbar‐Jacob</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Mortimer‐Stephens</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dunbar‐Jacob J, Mortimer‐Stephens MK. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54:S57‐S60.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>S57</start><end>S60</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Epidemiol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>54</number></detail><extent unit="pages"><start>S57</start><end>S60</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Variation in patterns of highly active antiretroviral therapy (HAART) adherence</title></titleInfo><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Levine</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CH</namePart><namePart type="family">Hinkin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Castellon</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Levine AJ, Hinkin CH, Castellon SA, et al. Variation in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;3:355‐362.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>355</start><end>362</end></extent></part><relatedItem type="host"><titleInfo><title>AIDS Behav</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>355</start><end>362</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Better physician‐patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Schneider</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Kaplan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Greenfield</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IB</namePart><namePart type="family">Wilson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician‐patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19:1096‐1103.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>1096</start><end>1103</end></extent></part><relatedItem type="host"><titleInfo><title>J Gen Intern Med</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>1096</start><end>1103</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Medication adherence in person with cardiovascular disease</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dunbar‐Jacob</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Bohachick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MK</namePart><namePart type="family">Mortimer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Sereika</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dunbar‐Jacob J, Bohachick P, Mortimer MK, Sereika SM. Medication adherence in person with cardiovascular disease. J Cardiovasc Nurs. 2003;3:209‐218.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>209</start><end>218</end></extent></part><relatedItem type="host"><titleInfo><title>J Cardiovasc Nurs</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>209</start><end>218</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white</title></titleInfo><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Apter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RC</namePart><namePart type="family">Boston</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">George</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Apter AJ, Boston RC, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white. J Allergy Clin Immunol. 2003;111:1219‐1226.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1219</start><end>1226</end></extent></part><relatedItem type="host"><titleInfo><title>J Allergy Clin Immunol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>111</number></detail><extent unit="pages"><start>1219</start><end>1226</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Practice parameter: evidence‐based guidelines for migraine headache (an evidence‐based review)</title></titleInfo><name type="personal"><namePart type="given">SD</namePart><namePart type="family">Silberstein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="corporate"><namePart>for the US Headache Consortium</namePart></name><genre>other</genre><part><date>2000</date></part></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>Topiramate for migraine prevention a randomized controlled trial</title></titleInfo><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Brandes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Saper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Diamond</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention a randomized controlled trial. JAMA. 2004;8:965‐973.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>965</start><end>973</end></extent></part><relatedItem type="host"><titleInfo><title>JAMA</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>965</start><end>973</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>A randomized, double‐blind, placebo‐controlled study of venlafaxine xr in out‐patients with tension‐type headache</title></titleInfo><name type="personal"><namePart type="given">NP</namePart><namePart type="family">Zissis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Harmoussi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Vlaikidis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Thomaidis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Georgiadis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Karageorgiou</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zissis NP, Harmoussi S, Vlaikidis N, Thomaidis T, Georgiadis G, Karageorgiou K. A randomized, double‐blind, placebo‐controlled study of venlafaxine xr in out‐patients with tension‐type headache. Cephalalgia. 2007;27:315‐323.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>315</start><end>323</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>315</start><end>323</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Improvement in quality of life and activity limitations in migraine after prophylaxis: A prospective longitudinal multicenter study</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">D'Amico</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Solari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Usai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Santoro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Bernardoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Frediani</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">D'Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F. Improvement in quality of life and activity limitations in migraine after prophylaxis: A prospective longitudinal multicenter study. Cephalalgia. 2006;26:691‐696.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>691</start><end>696</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>691</start><end>696</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>The efficacy and safety of venlafaxine in the prophylaxis of migraine</title></titleInfo><name type="personal"><namePart type="given">SN</namePart><namePart type="family">Ozyalcin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GK</namePart><namePart type="family">Talu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Kiziltan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Yucel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ertas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Disci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45:144‐152.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>144</start><end>152</end></extent></part><relatedItem type="host"><titleInfo><title>Headache</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>144</start><end>152</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>Mirtazapine is effective in the prophylactic treatment of chronic tension‐type headache</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Bendsten</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Rigmore Jensen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bendsten L, Rigmore Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension‐type headache. Neurology. 2004;62:1706‐1711.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>1706</start><end>1711</end></extent></part><relatedItem type="host"><titleInfo><title>Neurology</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>1706</start><end>1711</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Medication compliance among headache patients</title></titleInfo><name type="personal"><namePart type="given">RC</namePart><namePart type="family">Packard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">O'Connell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Packard RC, O'Connell P. Medication compliance among headache patients. Headache. 1986;26:416‐419.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>416</start><end>419</end></extent></part><relatedItem type="host"><titleInfo><title>Headache</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>416</start><end>419</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>If migraine prophylaxis does not work, think about compliance</title></titleInfo><name type="personal"><namePart type="given">TJ</namePart><namePart type="family">Steiner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Catarci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Hering</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Whirmarsh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EGM</namePart><namePart type="family">Couturier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Steiner TJ, Catarci T, Hering R, Whirmarsh T, Couturier EGM. If migraine prophylaxis does not work, think about compliance. Cephalalgia. 1994;14:463‐464.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>463</start><end>464</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>463</start><end>464</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Noncompliance may render migraine prophylaxis useless, but once‐daily regimens are better</title></titleInfo><name type="personal"><namePart type="given">WM</namePart><namePart type="family">Mullerners</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TE</namePart><namePart type="family">Whitemarsh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TJ</namePart><namePart type="family">Steiner</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mullerners WM, Whitemarsh TE, Steiner TJ. Noncompliance may render migraine prophylaxis useless, but once‐daily regimens are better. Cephalalgia. 1998;18:52‐56.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>52</start><end>56</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>52</start><end>56</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>Diabetes in primary care: Prospective associations between depression, nonadherence, and glycemic control</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Dirmaier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Watzke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">U</namePart><namePart type="family">Och</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Lehnert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Pieper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HU</namePart><namePart type="family">Wittchen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dirmaier J, Watzke B, Och U, Lehnert H, Pieper L, Wittchen HU. Diabetes in primary care: Prospective associations between depression, nonadherence, and glycemic control. Psychother Psychosom. 2010;79:172‐178.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>172</start><end>178</end></extent></part><relatedItem type="host"><titleInfo><title>Psychother Psychosom</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>172</start><end>178</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>The relationship between diabetes distress and clinical depression with glycemic control among patients with Type 2 diabetes</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Fisher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RE</namePart><namePart type="family">Glasgow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LA</namePart><namePart type="family">Stryker</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fisher L, Glasgow RE, Stryker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with Type 2 diabetes. Diabetes Care. 2010;33:1034‐1036. Epub 2010 Feb 11.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>1034</start><end>1036</end></extent></part><relatedItem type="host"><titleInfo><title>Diabetes Care</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>1034</start><end>1036</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>The link between religion and HAART adherence in pediatric HIV patients</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Park</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Nachman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Park J, Nachman S. The link between religion and HAART adherence in pediatric HIV patients. AIDS Care. 2010;15:1‐6.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>AIDS Care</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>Mediating roles of medication‐taking self‐efficacy and depressive symptoms on self‐reported medication adherence in persons with HIV: A questionnaire study</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Cha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Erlen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KH</namePart><namePart type="family">Kim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Sereika</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Caruthers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cha E, Erlen JA, Kim KH, Sereika SM, Caruthers D. Mediating roles of medication‐taking self‐efficacy and depressive symptoms on self‐reported medication adherence in persons with HIV: A questionnaire study. Int J Nurs Stud. 2008;45:1175‐1184.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>1175</start><end>1184</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Nurs Stud</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>1175</start><end>1184</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>Prevalence of frequent headaches in a population sample</title></titleInfo><name type="personal"><namePart type="given">AI</namePart><namePart type="family">Scher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WF</namePart><namePart type="family">Stewart</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Liberman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RB</namePart><namePart type="family">Lipton</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headaches in a population sample. Headache. 1998;38:497‐506.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>497</start><end>506</end></extent></part><relatedItem type="host"><titleInfo><title>Headache</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>497</start><end>506</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Race and electronically measured adherence to immunosuppressive medication after deceased donor renal transplantation</title></titleInfo><name type="personal"><namePart type="given">FL</namePart><namePart type="family">Weng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AK</namePart><namePart type="family">Israni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Marshall</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weng FL, Israni AK, Marshall MJ, et al. Race and electronically measured adherence to immunosuppressive medication after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16:1839‐1848.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>1839</start><end>1848</end></extent></part><relatedItem type="host"><titleInfo><title>J Am Soc Nephrol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>1839</start><end>1848</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>A prospective study of predictors of adherence to combination antiretroviral medication</title></titleInfo><name type="personal"><namePart type="given">CE</namePart><namePart type="family">Golin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RD</namePart><namePart type="family">Hays</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17:756‐765.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>756</start><end>765</end></extent></part><relatedItem type="host"><titleInfo><title>J Gen Intern Med</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>17</number></detail><extent unit="pages"><start>756</start><end>765</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Predictors of self‐reported adherence and plasma HIV concentration in patients on multidrug, antiretroviral regimens</title></titleInfo><name type="personal"><namePart type="given">AL</namePart><namePart type="family">Gifford</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Bormann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Shively</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BC</namePart><namePart type="family">Wright</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DD</namePart><namePart type="family">Richman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Bozzette</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self‐reported adherence and plasma HIV concentration in patients on multidrug, antiretroviral regimens. JAIDS. 2002;23:386‐395.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>386</start><end>395</end></extent></part><relatedItem type="host"><titleInfo><title>JAIDS</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>23</number></detail><extent unit="pages"><start>386</start><end>395</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age gender, and race</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Monane</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Bohn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JH</namePart><namePart type="family">Gurwitz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Glynn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Levin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Avorn</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age gender, and race. Am J Public Health. 1996;86:1805‐1808.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>1805</start><end>1808</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Public Health</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>86</number></detail><extent unit="pages"><start>1805</start><end>1808</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Whites and African American in specialty clinic respond equally well to treatment</title></titleInfo><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Holroyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Tietjen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heckman BD, Holroyd KA, Tietjen G, et al. Whites and African American in specialty clinic respond equally well to treatment. Cephalalgia. 2009;2:650‐661.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>650</start><end>661</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>650</start><end>661</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>Adherence to antiretroviral therapies among HIV‐infected rural persons</title></titleInfo><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Catz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TG</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JG</namePart><namePart type="family">Miller</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SC</namePart><namePart type="family">Kalichman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heckman BD, Catz S, Heckman TG, Miller JG, Kalichman SC. Adherence to antiretroviral therapies among HIV‐infected rural persons. AIDS Care. 2004;16:219‐230.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>219</start><end>230</end></extent></part><relatedItem type="host"><titleInfo><title>AIDS Care</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>219</start><end>230</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit33"><titleInfo><title>Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea</title></titleInfo><name type="personal"><namePart type="given">SS</namePart><namePart type="family">Jayawant</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SR</namePart><namePart type="family">Feldman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FT</namePart><namePart type="family">Camacho</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Yentzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Balkrishnan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jayawant SS, Feldman SR, Camacho FT, Yentzer B, Balkrishnan R. Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat. 2008;19:267‐273.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>267</start><end>273</end></extent></part><relatedItem type="host"><titleInfo><title>J Dermatolog Treat</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>267</start><end>273</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit34"><titleInfo><title>Medication adherence is a mediator of the relationship between ethnicity and event‐free survival in patients with heart failure</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Wu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TA</namePart><namePart type="family">Lennie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Jong</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wu J, Lennie TA, Jong MJ, et al. Medication adherence is a mediator of the relationship between ethnicity and event‐free survival in patients with heart failure. J Card Fail. 2010;16:142‐149.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>142</start><end>149</end></extent></part><relatedItem type="host"><titleInfo><title>J Card Fail</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>16</number></detail><extent unit="pages"><start>142</start><end>149</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit35"><titleInfo><title>Race‐ethnicity and nonadherence to prescription medications among seniors: Results of a national study</title></titleInfo><name type="personal"><namePart type="given">WF</namePart><namePart type="family">Gellad</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JS</namePart><namePart type="family">Haas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DG</namePart><namePart type="family">Safran</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gellad WF, Haas JS, Safran DG. Race‐ethnicity and nonadherence to prescription medications among seniors: Results of a national study. J Gen Intern Med. 2007;22:1572‐1578.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1572</start><end>1578</end></extent></part><relatedItem type="host"><titleInfo><title>J Gen Intern Med</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>1572</start><end>1578</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit36"><titleInfo><title>Factors associated with medication adherence in African American and white patients with bipolar disorder</title></titleInfo><name type="personal"><namePart type="given">DE</namePart><namePart type="family">Fleck</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PE</namePart><namePart type="family">Keck</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KB</namePart><namePart type="family">Corey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Strakowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Fleck DE, Keck PE, Corey KB, Strakowski SM. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry. 2005;66:646‐652.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>646</start><end>652</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Psychiatry</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>646</start><end>652</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit37"><titleInfo><title>Provider‐related barriers to rapid HIV testing in US urban non‐profit community clinics, community‐based organizations (CBOs) and hospitals</title></titleInfo><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Bogart</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Howerton</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Lange</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bogart LM, Howerton D, Lange J, et al. Provider‐related barriers to rapid HIV testing in US urban non‐profit community clinics, community‐based organizations (CBOs) and hospitals. AIDS Behav. 2010;14:697‐707.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>697</start><end>707</end></extent></part><relatedItem type="host"><titleInfo><title>AIDS Behav</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>697</start><end>707</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit38"><titleInfo><title>Self‐regulation, self‐efficacy, outcome expectations, and social support: Social cognitive theory and nutrition behavior</title></titleInfo><name type="personal"><namePart type="given">ES</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Winett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Wojcik</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Anderson ES, Winett RA, Wojcik JR. Self‐regulation, self‐efficacy, outcome expectations, and social support: Social cognitive theory and nutrition behavior. Ann Behav Med. 2007;34:304‐312.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>304</start><end>312</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Behav Med</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>304</start><end>312</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit39"><titleInfo><title>Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: Social support, self‐efficacy, outcome expectations, and self regulation in the guide‐to‐health trial</title></titleInfo><name type="personal"><namePart type="given">ES</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Winett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Wojcik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Anderson ES, Winett RA, Wojcik JR, Williams DM. Social cognitive mediators of change in a group randomized nutrition and physical activity intervention: Social support, self‐efficacy, outcome expectations, and self regulation in the guide‐to‐health trial. J Health Psychol. 2010;15:21‐32.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>21</start><end>32</end></extent></part><relatedItem type="host"><titleInfo><title>J Health Psychol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>21</start><end>32</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit40"><titleInfo><title>Physical activity in middle‐aged and young‐old adults: The roles of self‐efficacy barriers, outcome expectancies, self‐regulatory behaviors and social support</title></titleInfo><name type="personal"><namePart type="given">BJ</namePart><namePart type="family">Ayotte</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Margrett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hick‐Patrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ayotte BJ, Margrett JA, Hick‐Patrick J. Physical activity in middle‐aged and young‐old adults: The roles of self‐efficacy barriers, outcome expectancies, self‐regulatory behaviors and social support. J Health Psychol. 2010;15:173‐185.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>173</start><end>185</end></extent></part><relatedItem type="host"><titleInfo><title>J Health Psychol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>173</start><end>185</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit41"><titleInfo><title>Patterns of analgesic use, pain and self‐efficacy: A cross‐sectional study of patients attending a hospital rheumatology clinic</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Blamey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Jolly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Greenfield</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Jobanputra</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Blamey R, Jolly K, Greenfield S, Jobanputra P. Patterns of analgesic use, pain and self‐efficacy: A cross‐sectional study of patients attending a hospital rheumatology clinic. BMC Musculoskelet Disord. 2009;10:120‐137.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>120</start><end>137</end></extent></part><relatedItem type="host"><titleInfo><title>BMC Musculoskelet Disord</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>120</start><end>137</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit42"><titleInfo><title>Telephone nurse counseling for medication adherence in ulcerative colitis: A preliminary study</title></titleInfo><name type="personal"><namePart type="given">PF</namePart><namePart type="family">Cook</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Emiliozzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">El‐Hajj</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MM</namePart><namePart type="family">McCabe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cook PF, Emiliozzi S, El‐Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: A preliminary study. Patient Educ Couns. 2010;81:182‐186. Epub 2010 Jan 15.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>182</start><end>186</end></extent></part><relatedItem type="host"><titleInfo><title>Patient Educ Couns</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>182</start><end>186</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit43"><titleInfo><title>Factors influencing opioid‐taking self‐efficacy and analgesic adherence in Taiwanese outpatients with cancer</title></titleInfo><name type="personal"><namePart type="given">SY</namePart><namePart type="family">Liang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Yates</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Edwards</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Tsay</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Liang SY, Yates P, Edwards H, Tsay SL. Factors influencing opioid‐taking self‐efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psychooncology. 2008;21:1100‐1107.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1100</start><end>1107</end></extent></part><relatedItem type="host"><titleInfo><title>Psychooncology</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>1100</start><end>1107</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit44"><titleInfo><title>Social support and psychological adjustments to SARS: The mediating role of self‐care self‐efficacy</title></titleInfo><name type="personal"><namePart type="given">WW</namePart><namePart type="family">Mak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RW</namePart><namePart type="family">Law</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Woo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FM</namePart><namePart type="family">Cheung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mak WW, Law RW, Woo J, Cheung FM, Lee D. Social support and psychological adjustments to SARS: The mediating role of self‐care self‐efficacy. Psychol Health. 2009;24:161‐174.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>161</start><end>174</end></extent></part><relatedItem type="host"><titleInfo><title>Psychol Health</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>161</start><end>174</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit45"><titleInfo><title>Testing a social‐cognitive model of HIV transmission risk behaviors in HIV‐infected MSM with and without depression</title></titleInfo><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Safren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Traeger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Skeer</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Safren SA, Traeger L, Skeer MR, et al. Testing a social‐cognitive model of HIV transmission risk behaviors in HIV‐infected MSM with and without depression. Health Psychol. 2010;29:215‐221.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>215</start><end>221</end></extent></part><relatedItem type="host"><titleInfo><title>Health Psychol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>215</start><end>221</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit46"><titleInfo><title>A longitudinal evaluation of a social support model of medication adherence among HIV‐positive men and women on antiretroviral therapy</title></titleInfo><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Simoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Frick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Huang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV‐positive men and women on antiretroviral therapy. Health Psychol. 2006;25:74‐81.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>74</start><end>81</end></extent></part><relatedItem type="host"><titleInfo><title>Health Psychol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>74</start><end>81</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit47"><titleInfo><title>Self‐efficacy</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bandura</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Encyclopedia of Human Behavior</title></titleInfo><originInfo><publisher>Academic Press</publisher></originInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>71</start><end>81</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit48"><titleInfo><title>Race and sex differences in cutaneous pain perception</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Sheffield</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PL</namePart><namePart type="family">Biles</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Maixner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DS</namePart><namePart type="family">Sheps</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sheffield D, Biles PL, Maixner W, Sheps DS. Race and sex differences in cutaneous pain perception. Psychosom Med. 2000;62:517‐523.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>517</start><end>523</end></extent></part><relatedItem type="host"><titleInfo><title>Psychosom Med</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>517</start><end>523</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit49"><titleInfo><title>Racial differences in the experience of chronic pain</title></titleInfo><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Riley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Wade</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CD</namePart><namePart type="family">Myers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Sheffield</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RK</namePart><namePart type="family">Papas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DD</namePart><namePart type="family">Price</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Riley JL, Wade JB, Myers CD, Sheffield D, Papas RK, Price DD. Racial differences in the experience of chronic pain. Pain. 2002;100:291‐298.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>291</start><end>298</end></extent></part><relatedItem type="host"><titleInfo><title>Pain</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>291</start><end>298</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit50"><titleInfo><title>The International Classification of Headache Disorders, 2nd Edition</title></titleInfo><name type="corporate"><namePart>Headache Classification Subcommittee of the International Headache Society</namePart></name><genre>journal-article</genre><note type="citation/reference">Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24:1‐160.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>1</start><end>160</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>1</start><end>160</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit51"><titleInfo><title>Race differences in adherence to headache treatment appointments in persons with headache disorders</title></titleInfo><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Holroyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heckman BD, Holroyd KA, O'Donnell FJ, et al. Race differences in adherence to headache treatment appointments in persons with headache disorders. J Natl Med Assoc. 2008;100:243‐247.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>243</start><end>247</end></extent></part><relatedItem type="host"><titleInfo><title>J Natl Med Assoc</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>100</number></detail><extent unit="pages"><start>243</start><end>247</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit52"><titleInfo><title>Do psychiatric comorbidities influence headache treatment effectiveness? Results of a naturalistic longitudinal treatment study?</title></titleInfo><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Holroyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FJ</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Tietjen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Utley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Stillman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heckman BD, Holroyd KA, O'Donnell FJ, Tietjen G, Utley C, Stillman M. Do psychiatric comorbidities influence headache treatment effectiveness? Results of a naturalistic longitudinal treatment study? Pain. 2000;146:56‐64.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>56</start><end>64</end></extent></part><relatedItem type="host"><titleInfo><title>Pain</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>146</number></detail><extent unit="pages"><start>56</start><end>64</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit53"><titleInfo><title>Psychometric characteristics and measurement invariance of psychosocial headache measures in Caucasian and African American headache patients</title></titleInfo><name type="personal"><namePart type="given">BD</namePart><namePart type="family">Heckman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Berlin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Watakakosol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Pierre</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heckman BD, Berlin K, Watakakosol R, Pierre V. Psychometric characteristics and measurement invariance of psychosocial headache measures in Caucasian and African American headache patients. Cephalalgia. 2010;29:650‐651.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>650</start><end>651</end></extent></part><relatedItem type="host"><titleInfo><title>Cephalalgia</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>650</start><end>651</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit54"><titleInfo><title>Validity and utility of the PRIME‐MD Patient Health Questionnaire in assessment of 3,000 obstetric‐gynecologic patients: The PRIME‐MD patient health questionnaire obstetrics‐gynecology study</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Spitzer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Kroenke</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Spitzer R, Williams J, Kroenke K. Validity and utility of the PRIME‐MD Patient Health Questionnaire in assessment of 3,000 obstetric‐gynecologic patients: The PRIME‐MD patient health questionnaire obstetrics‐gynecology study. Am J Obstet Gynecol. 2000;183:759‐769.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>183</number></detail><extent unit="pages"><start>759</start><end>769</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Obstet Gynecol</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>183</number></detail><extent unit="pages"><start>759</start><end>769</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit55"><titleInfo><title>Perceived self‐efficacy and headache related disability</title></titleInfo><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">French</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Holroyd</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Cornelia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PT</namePart><namePart type="family">Malinoski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">O'Donnell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KR</namePart><namePart type="family">Hill</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">French DJ, Holroyd KA, Cornelia P, Malinoski PT, O'Donnell F, Hill KR. Perceived self‐efficacy and headache related disability. Headache. 2000;40:647‐656.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>647</start><end>656</end></extent></part><relatedItem type="host"><titleInfo><title>Headache</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>647</start><end>656</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit56"><titleInfo><title>Beck A. Cognitive Therapy and the Emotional Disorders. New York: Penguin; 1993.</title></titleInfo><note type="citation/reference">Beck A. Cognitive Therapy and the Emotional Disorders. New York: Penguin; 1993.</note><name type="personal"><namePart type="given">A</namePart><namePart type="family">Beck</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Penguin</publisher></originInfo><part><date>1993</date></part></relatedItem><relatedItem type="references" displayLabel="cit57"><titleInfo><title>A randomised controlled trial of cognitive behavioral therapy for adherence and depression (CBT‐AD) in HIV‐infected individuals</title></titleInfo><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Safren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">O'Clerigh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JY</namePart><namePart type="family">Tan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Safren SA, O'Clerigh C, Tan JY, et al. A randomised controlled trial of cognitive behavioral therapy for adherence and depression (CBT‐AD) in HIV‐infected individuals. Health Psychol. 2009;28:1‐10.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>1</start><end>10</end></extent></part><relatedItem type="host"><titleInfo><title>Health Psychol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>1</start><end>10</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit58"><titleInfo><title>Weissman MM, Markowitz JC, Klerman G. Clinican's Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press; 2007.</title></titleInfo><note type="citation/reference">Weissman MM, Markowitz JC, Klerman G. Clinican's Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press; 2007.</note><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Weissman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Markowitz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Klerman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Oxford University Press</publisher></originInfo><part><date>2007</date></part></relatedItem><identifier type="istex">8EF7539930E57B348997E197C425A36C95B1364B</identifier><identifier type="ark">ark:/67375/WNG-2Q6Q0P7D-5</identifier><identifier type="DOI">10.1111/j.1526-4610.2011.01866.x</identifier><identifier type="ArticleID">HEAD1866</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2011 American Headache Society</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-14</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-2Q6Q0P7D-5/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001F16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:8EF7539930E57B348997E197C425A36C95B1364B
|texte= Preventive Medication Adherence in African American and Caucasian Headache Patients
}}
| This area was generated with Dilib version V0.6.33. |  |